Our observations suggest that the reliance of pancreatic tumor growth and metastasis on MUC13-Glut-1 mediated glucose metabolism can be exploited for the development of novel targeted therapeutic strategies for pancreatic cancer. Here, MUC13 is linked to familial pancreatic carcinoma.